Details for New Drug Application (NDA): 018947
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
NDA 018947 describes SODIUM LACTATE IN PLASTIC CONTAINER, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the SODIUM LACTATE IN PLASTIC CONTAINER profile page.
The generic ingredient in SODIUM LACTATE IN PLASTIC CONTAINER is sodium lactate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium lactate profile page.
The generic ingredient in SODIUM LACTATE IN PLASTIC CONTAINER is sodium lactate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium lactate profile page.
Summary for 018947
| Tradename: | SODIUM LACTATE IN PLASTIC CONTAINER |
| Applicant: | Hospira |
| Ingredient: | sodium lactate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MEQ/ML | ||||
| Approval Date: | Sep 5, 1984 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
